2019
DOI: 10.1016/j.omto.2019.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Efficient Prostate Cancer Therapy with Tissue-Specific Homing Peptides Identified by Advanced Phage Display Technology

Abstract: Selective targeting of drugs to tumor cells is a key goal in oncology. Here, we performed an in vivo phage display to identify peptides that specifically target xenografted prostate cancer cells. This yielded three peptide candidates, LN1 (C-TGTPARQ-C), LN2 (C-KNSMFAT-C), and LN3 (C-TNKHSPK-C); each of these peptides was synthesized and evaluated for binding and biological activity. LN1 showed the highest avidity for LNCaP prostate cancer cells in vitro and was thus administered to tumor-bearing mice to evalua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(22 citation statements)
references
References 28 publications
0
20
0
Order By: Relevance
“…Peptides can be directly conjugated to the drug in cases where conjugation would not affect the drug’s activity and protection of the drug is not required. For instance, poor prognosis is associated with prostate cancer when the cancer is resistant to castration and/or when it metastasizes, but, at this point, treatment often needs to be halted due to poor systemic effects of currently available drugs [ 9 ]. One group used in vivo phage display to discover a peptide, C-TGTPARQ-C (LN1), with high affinity and selectivity for prostate cancer tissue [ 9 ].…”
Section: Targeting Moleculesmentioning
confidence: 99%
See 3 more Smart Citations
“…Peptides can be directly conjugated to the drug in cases where conjugation would not affect the drug’s activity and protection of the drug is not required. For instance, poor prognosis is associated with prostate cancer when the cancer is resistant to castration and/or when it metastasizes, but, at this point, treatment often needs to be halted due to poor systemic effects of currently available drugs [ 9 ]. One group used in vivo phage display to discover a peptide, C-TGTPARQ-C (LN1), with high affinity and selectivity for prostate cancer tissue [ 9 ].…”
Section: Targeting Moleculesmentioning
confidence: 99%
“…Advancement in technology has allowed for the use of in vivo phage display for the identification of peptides with higher selectivity for a specific tissue type. For example, one group sought to increase selectivity for xenografts of human prostate cancer in mice by performing multiple rounds of negative selection prior to in vivo phage display for a prostate cancer tissue homing peptide [ 9 ]. In each of three rounds of negative selection in mice and one subsequent round of negative selection in cynomolgus monkeys, the phage library was injected into the bloodstream and non-bound phages were harvested and identified [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…In addition to in vitro or ex vivo (e.g., against isolated cells), phage library selections can also be performed in vivo. The latter approach is used to identify tissue homing peptides for cell-specific targeting of therapeutics [77]. In contrast to phage library pannings to purified targets, selections against intact cells and in vivo screens are inherently more complicated as the library is exposed to many potential decoys, leading to high background [63].…”
Section: Cellular Approachmentioning
confidence: 99%